MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine
about
Germline genetic variants disturbing the Let-7/LIN28 double-negative feedback loop alter breast cancer susceptibilityDiagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fractionNeedles in the genetic haystack of lipid disorders: single nucleotide polymorphisms in the microRNA regulomeA Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanomaA let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapyEpigenome-Wide Association Studies (EWAS) in CancerMiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphismPharmacogenetics of microRNAs and microRNAs biogenesis machinery in pediatric acute lymphoblastic leukemiaPre-miR-146a (rs2910164 G>C) single nucleotide polymorphism is genetically and functionally associated with leprosyUsing bioinformatics to predict the functional impact of SNVsStatistical analysis of big data on pharmacogenomicsA genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS.miR-423-5p knockdown enhances the sensitivity of glioma stem cells to apigenin through the mitochondrial pathway.SNP-RFLPing 2: an updated and integrated PCR-RFLP tool for SNP genotyping.The evolving discipline of molecular epidemiology of cancer.Genetic variation in the 3'-UTR of CYP1A2, CYP2B6, CYP2D6, CYP3A4, NR1I2, and UGT2B7: potential effects on regulation by microRNA and pharmacogenomics relevance.Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding.MicroRNA polymorphisms: a giant leap towards personalized medicine.An 11-nt sequence polymorphism at the 3'UTR of human SFTPA1 and SFTPA2 gene variants differentially affect gene expression levels and miRNA regulation in cell cultureAssociation of miR-608 rs4919510 polymorphism and cancer risk: a meta-analysis based on 13,664 subjectsA dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma.Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective.Lack of association between miR-27a, miR-146a, miR-196a-2, miR-492 and miR-608 gene polymorphisms and colorectal cancerMicroRNA binding site polymorphisms as biomarkers in cancer management and research.Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer.A long non-coding RNA snaR contributes to 5-fluorouracil resistance in human colon cancer cells.Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients.Micromarkers: miRNAs in cancer diagnosis and prognosis.A miR-200b/200c/429-binding site polymorphism in the 3' untranslated region of the AP-2α gene is associated with cisplatin resistance.A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy.Catalog of microRNA seed polymorphisms in vertebratesGenetic polymorphisms in pre-microRNA genes as prognostic markers of colorectal cancerMicroRNAs as promising biomarkers in cancer diagnostics.Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survival.mirTarPri: improved prioritization of microRNA targets through incorporation of functional genomics dataMicroRNAs as biomarkers in rheumatic diseases.MicroRNAs: Meta-controllers of gene expression in synaptic activity emerge as genetic and diagnostic markers of human diseaseMiR-SNPs as markers of toxicity and clinical outcome in Hodgkin lymphoma patientsEpigenetics and cardiovascular disease.Dihydrofolate reductase gene variations in susceptibility to disease and treatment outcomes
P2860
Q21144942-223BC858-643A-4FEF-8BB2-6DD12065802BQ26771125-19606E55-C2FF-4EB3-BE87-D026D1F1E72BQ27015035-458CE1A6-36F5-4AC7-A369-73FAEA856A7EQ27851611-F863EF78-BF2C-4634-B8A8-ED6BF31398CBQ28287088-0AA57832-0D0B-48F8-BB53-EFD8DA9A854BQ28310536-D9F0CB6F-9854-4702-A549-8E943B22FC7AQ28472349-A5ACACAF-F947-470F-B070-1CF0189BDBA1Q28540685-D718DD7C-5C1F-4E61-AFA0-00CEBE2B2D90Q28542768-DF26F4C4-2DD4-4CB2-AA6C-7FAEEEB05833Q28744088-64410F39-828E-49A5-B9D1-7AFAEE735A34Q30619237-7A7F81B5-1E34-4309-BB81-E9DF8C10D5B0Q31034509-8C7235DE-1B17-44E2-B81E-2A855D4B653AQ32179160-49C033E7-05DC-4AF3-91D2-5AF9DF06E975Q33551006-215714FB-BBDB-4E1C-8A42-8646136FCBF3Q33575696-E440D0C4-0BAC-4D14-B5EC-1ECA0A415B99Q33708471-70C89FE4-F98C-47E1-B97A-83E7D2AD3729Q33764157-1E5F5329-D434-4F2F-9C65-CFBAA3D1D437Q33812664-377A7C54-DEB2-4882-848B-08FA0CDB6362Q33840389-29895861-33D5-4D2B-B90D-3D1516C94B5BQ33913814-B55225F5-6FAD-42CC-8C15-A92CD31ADDC5Q33974932-A4B331D7-7FF1-401C-BB67-A7456DCE3DC9Q33993320-1C41C1E7-BB0B-4E66-AACC-4502197C42FBQ34018423-F5F03155-44EB-432A-995B-EF3F213D8C99Q34019040-FF7F62CC-558F-4CA7-88F3-0989BFDD9F64Q34038394-D3D22B7F-3D9B-4769-AC84-9E3FC4C9DF98Q34043011-638893FA-C90D-4C0C-97B7-28E16FE15C8CQ34078876-A51A033E-4B2D-42DD-A80C-F4688C0FD6B9Q34108602-FDA7CF4C-DFC0-4CC6-9018-0D30C2390D31Q34110688-9BEC0615-2FE3-4F4D-AE24-B00E8815257AQ34138308-287B7EF9-3F83-4620-937F-A171CFC4670EQ34150000-E59A04BB-AE03-41CA-818C-A91469BBDC5CQ34227531-4937E8F0-1E58-487D-901A-89870CEC8883Q34417467-0F2EDAC7-7006-4D95-9A44-49CFD74E2C14Q34433762-F5CBFB72-58A6-427F-874E-D50B8FFD19ADQ34551668-790EAA7D-ABBD-4371-8BFF-1F8611C564B0Q34585272-4B59B1F8-0FB1-4CEE-8E5C-261C762AE17AQ34594189-96FCC076-F492-45E6-94B9-F979D0117CFDQ34738140-FDF3776B-D27C-428B-9353-8A90BEB1CBD5Q34788746-F8B902F1-A4A9-4560-B82E-5FC3CE08DEF0Q34807469-E90D1781-5C76-4737-B9B6-721D70D5548E
P2860
MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNA polymorphisms: the fu ...... gy and individualized medicine
@en
MicroRNA polymorphisms: the fu ...... y and individualized medicine.
@nl
type
label
MicroRNA polymorphisms: the fu ...... gy and individualized medicine
@en
MicroRNA polymorphisms: the fu ...... y and individualized medicine.
@nl
prefLabel
MicroRNA polymorphisms: the fu ...... gy and individualized medicine
@en
MicroRNA polymorphisms: the fu ...... y and individualized medicine.
@nl
P2860
P921
P1433
P1476
MicroRNA polymorphisms: the fu ...... gy and individualized medicine
@en
P2093
Joseph R Bertino
Prasun J Mishra
P2860
P304
P356
10.2217/14622416.10.3.399
P577
2009-03-01T00:00:00Z